Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Short Interest Update

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the target of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a decline of 99.0% from the February 29th total of 9,900 shares. Based on an average trading volume of 37,700 shares, the days-to-cover ratio is currently 0.0 days.

Mydecine Innovations Group Stock Performance

Shares of OTCMKTS:MYCOF remained flat at $0.01 on Thursday. The stock had a trading volume of 1,124 shares, compared to its average volume of 26,468. Mydecine Innovations Group has a 12 month low of $0.00 and a 12 month high of $0.66. The company’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.05.

Mydecine Innovations Group Company Profile

Mydecine Innovations Group Inc, a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004.